Neurology Minute
Efficacy and Safety of Symbravo® in Participants with Migraine Experiencing an Inadequate Response to Oral CGRP Inhibitors
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:02:10
- More information
Informações:
Synopsis
Dr. Bradley Ong shares early insights from the EMERGE trial, presented at the American Headache Society’s 67th Annual Scientific Meeting in June 2025. Show reference: https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14957
